Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHend.eur.focus Regulatory News (HEFT)

Share Price Information for Hend.eur.focus (HEFT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 181.00
Bid: 180.00
Ask: 181.50
Change: 0.00 (0.00%)
Spread: 1.50 (0.833%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 181.00
HEFT Live PriceLast checked at -
Henderson European Focus Trust is an Investment Trust

seeks to maximise total return from a focused portfolio of listed stocks, mainly in Continental Europe.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results analysis from Kepler Trust Intelligence

8 Dec 2022 10:26

RNS Number : 0708J
Henderson European Focus Trust PLC
08 December 2022
 

Henderson European Focus Trust (HEFT)

08/12/2022

 

Results analysis from Kepler Trust Intelligence

For the financial year ending 30/09/2022, Henderson European Focus Trust (HEFT) reported a NAV total return of -13.1% and a share price return of -18.3%, underperforming the -12.8% return of its benchmark, the FTSE World Europe ex UK Index. Noticeably, HEFT's returns were significantly better than the AIC Europe sector average of -19.3%.

The managers' more valuation-conscious approach helped them during the year versus the growth-oriented peer group, with holdings in the energy sector in particular contributing to performance. However, versus the benchmark the consumer exposure was unhelpful while the unexpected Russian invasion of Ukraine also hurt returns.

At the start of the financial year, the board took advantage of low interest rates and locked in cheap long-term borrowing. In two tranches of loan notes, EUR35m was borrowed for 25 and 30 years at a weighted average interest rate of just 1.57 %. This provides structural gearing of 9.7% of year-end NAV on a gross basis which, in addition to the flexible borrowings in place, affords the fund managers the flexibility to make full use of gearing as opportunities present themselves.

Kepler View

It has been a challenging period for equity investors as economies struggle with the impact of rocketing inflation and an exceptionally fast increase in US interest rates. Henderson European Focus Trust's (HEFT) flexible, valuation-conscious approach has helped the trust do better than the peer group average in NAV total return terms, but the returns have nonetheless been disappointing on an absolute basis, and marginally behind those of the benchmark. Looking forward, we think HEFT looks like an interesting way to invest in a beaten-up European equity market and play a potential recovery. First, the managers' flexible approach means they can take advantage of mis-pricings across the market - sentiment is so poor towards equities that we think there are likely to be opportunities in good companies swept up in the negativity in multiple industries. Secondly, the very cheap long-term gearing affords maximum flexibility to take advantage of any eventual market recovery.

Tom O'Hara and John Bennett argue that Europe is "exceptionally cheap in pockets". In particular, they argue that the market has not yet acknowledged we have seen a macroeconomic regime shift. They believe that inflation is likely to remain higher than pre-pandemic levels for a long time, even after the current spike has declined. In their view the market has not priced this in, which leads to opportunities in "quality, cash generative champions across energy, materials and industrials, with strong management teams and, most importantly, pricing power." In recent months, the managers have been adding to existing positions which possess these qualities, taking advantage of share price weakness. Examples include chemicals company Arkem, which was added to on a multiple of less than 6 times enterprise value to earnings before interest, tax and depreciation (EV/EBITDA). Meanwhile construction and materials producer Holcim was added to on less than 7 times EV/EBITDA and industrial tool manufacturer Atlas Copco was added to after a 30% YTD decline. Though these companies have some cyclical sensitivity, Tom and John believe that they will be relative winners and will deliver strong returns to shareholders. Accordingly, they are explicit about their appetite to increase the trust's gearing into the expected recovery, utilising the low-cost loan notes placed earlier in 2022.

CLICK HERE TO READ THE FULL REPORT  Visit Kepler Trust Intelligence for more high quality independent investment trust research.

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAZZMGZGRFGZZM
Date   Source Headline
3rd May 202412:19 pmRNSNet Asset Value(s)
2nd May 202412:16 pmRNSNet Asset Value(s)
1st May 20241:00 pmRNSNet Asset Value(s)
30th Apr 20241:42 pmRNSNet Asset Value(s)
29th Apr 20244:28 pmRNSNet Asset Value(s)
26th Apr 20241:26 pmRNSNet Asset Value(s)
26th Apr 20247:00 amRNSCompliance with Market Abuse Regulation
25th Apr 202412:29 pmRNSNet Asset Value(s)
24th Apr 202412:32 pmRNSNet Asset Value(s)
23rd Apr 20244:26 pmRNSDoc re. Monthly Factsheet as at 31 March 2024
23rd Apr 202411:46 amRNSNet Asset Value(s)
22nd Apr 20243:37 pmRNSNet Asset Value(s)
19th Apr 202412:33 pmRNSNet Asset Value(s)
18th Apr 20241:07 pmRNSNet Asset Value(s)
17th Apr 202412:02 pmRNSNet Asset Value(s)
16th Apr 202412:01 pmRNSNet Asset Value(s)
15th Apr 20243:49 pmRNSNet Asset Value(s)
12th Apr 202412:28 pmRNSNet Asset Value(s)
11th Apr 202411:56 amRNSNet Asset Value(s)
10th Apr 202412:59 pmRNSNet Asset Value(s)
9th Apr 202412:59 pmRNSNet Asset Value(s)
8th Apr 20242:23 pmRNSNet Asset Value(s)
5th Apr 20241:27 pmRNSNet Asset Value(s)
4th Apr 202411:56 amRNSNet Asset Value(s)
3rd Apr 202412:36 pmRNSNet Asset Value(s)
2nd Apr 20244:09 pmRNSNet Asset Value(s)
28th Mar 20242:52 pmRNSNet Asset Value(s)
27th Mar 202412:55 pmRNSNet Asset Value(s)
26th Mar 202412:03 pmRNSNet Asset Value(s)
25th Mar 20244:20 pmRNSNet Asset Value(s)
22nd Mar 202411:33 amRNSNet Asset Value(s)
21st Mar 20244:34 pmRNSMonthly Factsheet as at 29 February 2024
21st Mar 202412:11 pmRNSNet Asset Value(s)
20th Mar 202411:44 amRNSNet Asset Value(s)
19th Mar 202411:57 amRNSNet Asset Value(s)
18th Mar 20245:02 pmRNSNet Asset Value(s)
15th Mar 202412:16 pmRNSNet Asset Value(s)
14th Mar 20242:00 pmRNSProposed merger of interests of HEFT and HNE
14th Mar 202410:45 amRNSNet Asset Value(s)
13th Mar 202412:42 pmRNSNet Asset Value(s)
12th Mar 20242:02 pmRNSNet Asset Value(s)
11th Mar 20241:45 pmRNSNet Asset Value(s)
8th Mar 202412:05 pmRNSNet Asset Value(s)
7th Mar 202410:18 amRNSNet Asset Value(s)
6th Mar 202411:44 amRNSNet Asset Value(s)
5th Mar 20241:02 pmRNSNet Asset Value(s)
4th Mar 20243:14 pmRNSNet Asset Value(s)
1st Mar 202412:41 pmRNSNet Asset Value(s)
29th Feb 202411:08 amRNSNet Asset Value(s)
28th Feb 202411:27 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.